| James Orsini, MD | |
|
1 Clara Maass Dr Ste 200, Belleville, NJ 07109-3550 | |
| (973) 751-8880 | |
| (973) 751-8950 |
| Full Name | James Orsini |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 50 Years |
| Location | 1 Clara Maass Dr Ste 200, Belleville, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922084185 | NPI | - | NPPES |
| 4763904 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 25MA03159300 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hackensackumc Mountainside | Montclair, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Jersey Cancer Care, Pa | 3971603788 | 10 |
News Archive
Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. MammaPrint, the company's lead product, is the only FDA-cleared breast cancer recurrence test.
Researchers continue to achieve a better understanding of SARS-CoV-2, the virus behind the ongoing COVID-19 pandemic. One such effort has been reported in a new preprint on the bioRxiv server, dealing with the phenomenon of backtracking.
Usually, scientists study the molecular biology of cancer to find new treatments, but sometimes, it is the other way round: when trying to find new treatments, scientists find key information on cancer biology.
Metal-binding agents rubbed into the skin, prescribed by some alternative practitioners for the treatment of autism, are not absorbed and therefore are unlikely to be effective at helping the body excrete excess mercury. The study by Jennifer Cohen and Michelle Ruha from Banner Good Samaritan Medical Center in the US, and their colleagues, provides evidence against the use of these treatments in children with autism.
› Verified 8 days ago
| Entity Name | New Jersey Cancer Care, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447315502 PECOS PAC ID: 3971603788 Enrollment ID: O20070710000160 |
News Archive
Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. MammaPrint, the company's lead product, is the only FDA-cleared breast cancer recurrence test.
Researchers continue to achieve a better understanding of SARS-CoV-2, the virus behind the ongoing COVID-19 pandemic. One such effort has been reported in a new preprint on the bioRxiv server, dealing with the phenomenon of backtracking.
Usually, scientists study the molecular biology of cancer to find new treatments, but sometimes, it is the other way round: when trying to find new treatments, scientists find key information on cancer biology.
Metal-binding agents rubbed into the skin, prescribed by some alternative practitioners for the treatment of autism, are not absorbed and therefore are unlikely to be effective at helping the body excrete excess mercury. The study by Jennifer Cohen and Michelle Ruha from Banner Good Samaritan Medical Center in the US, and their colleagues, provides evidence against the use of these treatments in children with autism.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Orsini, MD 1 Clara Maass Dr Ste 200, Belleville, NJ 07109-3550 Ph: (973) 751-8880 | James Orsini, MD 1 Clara Maass Dr Ste 200, Belleville, NJ 07109-3550 Ph: (973) 751-8880 |
News Archive
Agendia, a world leader in molecular cancer diagnostics, today announced that researchers from Agendia and leading academic centers in the U.S. and Europe will present data from multiple studies concerning Agendia's assays MammaPrint(R), BluePrint(TM), and ColoPrint(TM) at the American Society of Clinical Oncology Annual Meeting, June 4 - 8, 2010, at McCormick Place in Chicago. MammaPrint, the company's lead product, is the only FDA-cleared breast cancer recurrence test.
Researchers continue to achieve a better understanding of SARS-CoV-2, the virus behind the ongoing COVID-19 pandemic. One such effort has been reported in a new preprint on the bioRxiv server, dealing with the phenomenon of backtracking.
Usually, scientists study the molecular biology of cancer to find new treatments, but sometimes, it is the other way round: when trying to find new treatments, scientists find key information on cancer biology.
Metal-binding agents rubbed into the skin, prescribed by some alternative practitioners for the treatment of autism, are not absorbed and therefore are unlikely to be effective at helping the body excrete excess mercury. The study by Jennifer Cohen and Michelle Ruha from Banner Good Samaritan Medical Center in the US, and their colleagues, provides evidence against the use of these treatments in children with autism.
› Verified 8 days ago
Dr. Etan B Spira, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5 Franklin Ave, Suite 109, Belleville, NJ 07109 Phone: 973-759-7240 Fax: 973-759-7243 | |
Dr. Jimmy Martins Paulo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr Ste 202, Belleville, NJ 07109 Phone: 973-450-2433 Fax: 973-450-2434 | |
Hemalatha Vasireddy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr Ste 200, Belleville, NJ 07109 Phone: 973-751-8880 Fax: 973-751-8950 | |
Dr. Mario A Criscito, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 50 Newark Ave, Suite 204, Belleville, NJ 07109 Phone: 973-450-2158 Fax: 973-450-2027 | |
John Daconti, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 77 Newark Ave, Suite 3 & 4, Belleville, NJ 07109 Phone: 973-528-2160 Fax: 973-528-2165 | |
Jaxon James Fernandes, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Clara Maass Dr, Belleville, NJ 07109 Phone: 973-450-2000 | |
Dr. Dianne Walker, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 303 Belmont Ave, Belleville, NJ 07109 Phone: 973-751-4818 Fax: 973-751-4886 |